Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Tipranavir/Ritonavir in Advanced HIV-1
NCT00144287Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tipranavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Started May 2004; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00144287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144287.